Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression
ABSTRACT Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role i...
Gespeichert in:
Veröffentlicht in: | The FASEB journal 2006-02, Vol.20 (2), p.365-367 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 367 |
---|---|
container_issue | 2 |
container_start_page | 365 |
container_title | The FASEB journal |
container_volume | 20 |
creator | Salameh, A Frenzel, C Boldt, A Rassler, B Glawe, I Schulte, J Můhlberg, K Zimmer, H.-G Pfeiffer, D Dhein, S |
description | ABSTRACT
Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease. |
doi_str_mv | 10.1096/fj.05-4871fje |
format | Article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1096_fj_05_4871fje</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FSB2FJ054871FJE</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EoqVw5Ap-ARf_JE7CDaoGqCpxKD1xsNaOnSZKk8hpBH17UlqJG6fV7nwzWg1Ct4xOGU3kgyunNCRBHDFX2jM0ZqGgRMaSnqMxjRNOpBTxCF11XUkpZZTJSzRiUoRcBvEYfa56bTa-qQuDoWo3QDDUGdZ2BwQyb2vr80HyNu8r2BVNjRuHDfisAINzaHHZ1-b33vpmZ4sa2-_W264bTtfowkHV2ZvTnKB1Ov-YvZLl-8vb7GlJTCD4nCTZ8JXlPLA61pYxyaQxLABgNgioZHEgBLhEDLrjLnRC6shkSWhAR1xoLiaIHHONb7rOW6daX2zB7xWj6lCScqWioTqVNPB3R77t9dZmf_SplQF4PAJfRWX3_6epdPXM0wUND3u6mA_m-6PZQaMg90Wn1itOmRjKD3kkufgBrr5_kg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Salameh, A ; Frenzel, C ; Boldt, A ; Rassler, B ; Glawe, I ; Schulte, J ; Můhlberg, K ; Zimmer, H.-G ; Pfeiffer, D ; Dhein, S</creator><creatorcontrib>Salameh, A ; Frenzel, C ; Boldt, A ; Rassler, B ; Glawe, I ; Schulte, J ; Můhlberg, K ; Zimmer, H.-G ; Pfeiffer, D ; Dhein, S</creatorcontrib><description>ABSTRACT
Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.05-4871fje</identifier><identifier>PMID: 16352648</identifier><language>eng</language><publisher>United States: Federation of American Societies for Experimental Biology</publisher><subject>Adrenergic alpha-Agonists - pharmacology ; Adrenergic beta-Agonists - pharmacology ; alpha‐adrenoceptor ; Animals ; beta‐adrenoceptor ; cardiomyocytes ; catecholamine • noradrenaline ; Cells, Cultured ; Connexin 43 - genetics ; Connexin 43 - metabolism ; connexins ; Connexins - genetics ; Connexins - metabolism ; dual whole‐cell voltage clamp ; Gap Junction alpha-5 Protein ; Gap Junctions - metabolism ; Gene Expression Regulation - drug effects ; Isoproterenol - pharmacology ; Myocytes, Cardiac - metabolism ; Phenylephrine - pharmacology ; Rats ; Rats, Wistar ; Receptors, Adrenergic, alpha - metabolism ; Receptors, Adrenergic, beta - metabolism</subject><ispartof>The FASEB journal, 2006-02, Vol.20 (2), p.365-367</ispartof><rights>FASEB</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</citedby><cites>FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffj.05-4871fje$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffj.05-4871fje$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16352648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salameh, A</creatorcontrib><creatorcontrib>Frenzel, C</creatorcontrib><creatorcontrib>Boldt, A</creatorcontrib><creatorcontrib>Rassler, B</creatorcontrib><creatorcontrib>Glawe, I</creatorcontrib><creatorcontrib>Schulte, J</creatorcontrib><creatorcontrib>Můhlberg, K</creatorcontrib><creatorcontrib>Zimmer, H.-G</creatorcontrib><creatorcontrib>Pfeiffer, D</creatorcontrib><creatorcontrib>Dhein, S</creatorcontrib><title>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>ABSTRACT
Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.</description><subject>Adrenergic alpha-Agonists - pharmacology</subject><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>alpha‐adrenoceptor</subject><subject>Animals</subject><subject>beta‐adrenoceptor</subject><subject>cardiomyocytes</subject><subject>catecholamine • noradrenaline</subject><subject>Cells, Cultured</subject><subject>Connexin 43 - genetics</subject><subject>Connexin 43 - metabolism</subject><subject>connexins</subject><subject>Connexins - genetics</subject><subject>Connexins - metabolism</subject><subject>dual whole‐cell voltage clamp</subject><subject>Gap Junction alpha-5 Protein</subject><subject>Gap Junctions - metabolism</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Isoproterenol - pharmacology</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Phenylephrine - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Adrenergic, alpha - metabolism</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1OwzAQhC0EoqVw5Ap-ARf_JE7CDaoGqCpxKD1xsNaOnSZKk8hpBH17UlqJG6fV7nwzWg1Ct4xOGU3kgyunNCRBHDFX2jM0ZqGgRMaSnqMxjRNOpBTxCF11XUkpZZTJSzRiUoRcBvEYfa56bTa-qQuDoWo3QDDUGdZ2BwQyb2vr80HyNu8r2BVNjRuHDfisAINzaHHZ1-b33vpmZ4sa2-_W264bTtfowkHV2ZvTnKB1Ov-YvZLl-8vb7GlJTCD4nCTZ8JXlPLA61pYxyaQxLABgNgioZHEgBLhEDLrjLnRC6shkSWhAR1xoLiaIHHONb7rOW6daX2zB7xWj6lCScqWioTqVNPB3R77t9dZmf_SplQF4PAJfRWX3_6epdPXM0wUND3u6mA_m-6PZQaMg90Wn1itOmRjKD3kkufgBrr5_kg</recordid><startdate>200602</startdate><enddate>200602</enddate><creator>Salameh, A</creator><creator>Frenzel, C</creator><creator>Boldt, A</creator><creator>Rassler, B</creator><creator>Glawe, I</creator><creator>Schulte, J</creator><creator>Můhlberg, K</creator><creator>Zimmer, H.-G</creator><creator>Pfeiffer, D</creator><creator>Dhein, S</creator><general>Federation of American Societies for Experimental Biology</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200602</creationdate><title>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</title><author>Salameh, A ; Frenzel, C ; Boldt, A ; Rassler, B ; Glawe, I ; Schulte, J ; Můhlberg, K ; Zimmer, H.-G ; Pfeiffer, D ; Dhein, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adrenergic alpha-Agonists - pharmacology</topic><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>alpha‐adrenoceptor</topic><topic>Animals</topic><topic>beta‐adrenoceptor</topic><topic>cardiomyocytes</topic><topic>catecholamine • noradrenaline</topic><topic>Cells, Cultured</topic><topic>Connexin 43 - genetics</topic><topic>Connexin 43 - metabolism</topic><topic>connexins</topic><topic>Connexins - genetics</topic><topic>Connexins - metabolism</topic><topic>dual whole‐cell voltage clamp</topic><topic>Gap Junction alpha-5 Protein</topic><topic>Gap Junctions - metabolism</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Isoproterenol - pharmacology</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Phenylephrine - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Adrenergic, alpha - metabolism</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salameh, A</creatorcontrib><creatorcontrib>Frenzel, C</creatorcontrib><creatorcontrib>Boldt, A</creatorcontrib><creatorcontrib>Rassler, B</creatorcontrib><creatorcontrib>Glawe, I</creatorcontrib><creatorcontrib>Schulte, J</creatorcontrib><creatorcontrib>Můhlberg, K</creatorcontrib><creatorcontrib>Zimmer, H.-G</creatorcontrib><creatorcontrib>Pfeiffer, D</creatorcontrib><creatorcontrib>Dhein, S</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salameh, A</au><au>Frenzel, C</au><au>Boldt, A</au><au>Rassler, B</au><au>Glawe, I</au><au>Schulte, J</au><au>Můhlberg, K</au><au>Zimmer, H.-G</au><au>Pfeiffer, D</au><au>Dhein, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2006-02</date><risdate>2006</risdate><volume>20</volume><issue>2</issue><spage>365</spage><epage>367</epage><pages>365-367</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>ABSTRACT
Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.</abstract><cop>United States</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>16352648</pmid><doi>10.1096/fj.05-4871fje</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0892-6638 |
ispartof | The FASEB journal, 2006-02, Vol.20 (2), p.365-367 |
issn | 0892-6638 1530-6860 |
language | eng |
recordid | cdi_crossref_primary_10_1096_fj_05_4871fje |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
subjects | Adrenergic alpha-Agonists - pharmacology Adrenergic beta-Agonists - pharmacology alpha‐adrenoceptor Animals beta‐adrenoceptor cardiomyocytes catecholamine • noradrenaline Cells, Cultured Connexin 43 - genetics Connexin 43 - metabolism connexins Connexins - genetics Connexins - metabolism dual whole‐cell voltage clamp Gap Junction alpha-5 Protein Gap Junctions - metabolism Gene Expression Regulation - drug effects Isoproterenol - pharmacology Myocytes, Cardiac - metabolism Phenylephrine - pharmacology Rats Rats, Wistar Receptors, Adrenergic, alpha - metabolism Receptors, Adrenergic, beta - metabolism |
title | Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subchronic%20alpha-%20and%20beta-adrenergic%20regulation%20of%20cardiac%20gap%20junction%20protein%20expression&rft.jtitle=The%20FASEB%20journal&rft.au=Salameh,%20A&rft.date=2006-02&rft.volume=20&rft.issue=2&rft.spage=365&rft.epage=367&rft.pages=365-367&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.05-4871fje&rft_dat=%3Cwiley_cross%3EFSB2FJ054871FJE%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16352648&rfr_iscdi=true |